In this video, health-care analyst David Williamson discusses how migraines may one day be cured thanks to a common vegetable found in grocery stores. Find out why big biotech Amgen is so excited about red hot chili peppers and why migraine sufferers can't unfortunately run out to the store and eat a handful to prevent their painful symptoms.
Amgen stumbled this quarter, but the stock's recent sell-off may be overdone, and this video highlights a number of intriguing drugs besides the migraine cure in its pipeline.
The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.